Stephane Giraudier

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications

Scalable genotyping in fixed transcriptomes resolves clonal heterogeneity via single-cell sequencing.

Scalable genotyping in fixed transcriptomes resolves clonal heterogeneity via single-cell sequencing.

Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026

Genetic screening of triple negative thrombocytosis patients identifies germline MPL compound mutations and SH2B3/LNK truncating mutations.

Genetic screening of triple negative thrombocytosis patients identifies germline MPL compound mutations and SH2B3/LNK truncating mutations.

Journal: Haematologica
Published: March 06, 2026

Genetic screening of triple negative thrombocytosis patients identifies germline MPL compound mutations and SH2B3/LNK truncating mutations.

Genetic screening of triple negative thrombocytosis patients identifies germline MPL compound mutations and SH2B3/LNK truncating mutations.

Journal: Haematologica
Published: March 06, 2026

FOXP1 contributes to murine hematopoietic stem cell functionality.

FOXP1 contributes to murine hematopoietic stem cell functionality.

Journal: Experimental hematology
Published: February 09, 2025

Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera.

Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera.

Journal: Leukemia
Published: August 13, 2024

JAK2V617F-dependent down regulation of SHP-1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF-β.

JAK2V617F-dependent down regulation of SHP-1 expression participates in the selection of myeloproliferative neoplasm cells in the presence of TGF-β.

Journal: Journal of cellular and molecular medicine
Published: June 07, 2024

Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis.

Association of MPL K39N and R102P heterozygous germline mutations lead to hereditary thrombocytosis.

Journal: American journal of hematology
Published: March 09, 2024

JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Journal: Nature communications
Published: February 23, 2024

Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.

Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells.

Journal: Leukemia
Published: November 13, 2023

Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.

Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.

Journal: Haematologica
Published: October 27, 2023

Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.

Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PM.

Journal: American journal of hematology
Published: September 29, 2023

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.

Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification.

Journal: Leukemia
Published: September 05, 2023
Showing 1-12 of 71

Last Updated: 09/26/2026